copy and paste this google map to your website or blog!
Press copy button and paste into your blog or website.
(Please switch to 'HTML' mode when posting into your blog. Examples: WordPress Example, Blogger Example)
Cordis Corporation’s CYPHER SELECT(R) Plus Sirolimus . . . - BioSpace WARREN, N J --(BUSINESS WIRE)--Cordis Corporation today announced that it has received CE mark approval to market the CYPHER SELECT® Plus Sirolimus-eluting Coronary Stent for the treatment of acute myocardial infarction (AMI), more commonly known as a heart attack CE mark approval means that the